Jisandai/Bingtongsha is available in pharmacies. How to distinguish the authentic and fake channels?
Epclusa is a direct-acting antiviral drug mainly used to treat hepatitis C (HCV). The two drugs used in combination - Sofosbuvir and Velpatasvir - can effectively inhibit the replication of the hepatitis C virus, thereby achieving the effect of curing hepatitis C. The drug is suitable for patients with hepatitis C of different genotypes (types 1 to 6), especially those with liver cirrhosis, and can also play a significant therapeutic role. The treatment course for GISANDA is usually 12 weeks, but for some patients, the treatment length may be adjusted.

Epclusa (Epclusa) is widely used in patients with hepatitis C without other complications and has become one of the global standard treatments. Not only does it treat acute hepatitis C, it is also effective against chronic hepatitis C, especially in patients who have not been treated before or have been treated with other therapies without success. The drug is considered a "revolutionary" treatment for hepatitis C and can significantly reduce liver damage and prevent further complications.
Regarding drug purchase channels, Jisandai has been officially launched in mainland China and has been included in medical insurance. Patients can purchase it through hospitals or pharmacies. In order to ensure the authenticity of medicines, patients need to pay special attention to the channels through which they are purchased. Avoid purchasing drugs through informal channels, as there may be a risk of purchasing fake or inferior drugs through informal channels.
On the other hand, the price of Jisandai is relatively cheap abroad, especially the generic version in countries such as India and Bangladesh. The price is usually much cheaper than the original drug. Although the price of these generic drugs is lower, their ingredients and efficacy are basically the same as those of the original drugs. Therefore, many patients choose to purchase generic drugs through foreign channels. Especially for patients with heavy financial burdens, generic drugs provide a more affordable option.
Reference: https://www.epclusa.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)